Researchers have identified metformin as a possible treatment for atrial fibrillation (AF). They advise that the treatment be repurposed for this indication.

Genome-wide association studies (GWASs) have identified about 100 AF susceptibility loci. This study used advanced computation and genetic sequencing to determine if metformin’s targets overlap significantly with genes...